Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.
Frequently asked questions
What sector does Pathfinder Cell Therapy Inc (PFND) operate in?
Pathfinder Cell Therapy Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Pathfinder Cell Therapy Inc (PFND) current stock price?
As of the latest data, Pathfinder Cell Therapy Inc stock price is $0.00, with a previous close of $0.00.
What is Pathfinder Cell Therapy Inc (PFND) current market capitalization?
Pathfinder Cell Therapy Inc market cap is approximately 66.72 thousand.
Does Pathfinder Cell Therapy Inc (PFND) pay dividends?
No. Pathfinder Cell Therapy Inc does not pay a dividend.
What is Pathfinder Cell Therapy Inc (PFND) beta (volatility) score?
Pathfinder Cell Therapy Inc has a beta of -30.810, indicating lower volatility than the overall market.